Association between lipoprotein(a) concentration and the risk of stroke in the Chinese Han population: a

Hanhui Fu1, Dingding Zhang2, Rui Zhu3

  • 1Department of Neurology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences, Beijing 100730, China.

Insights

Elevated Lipoprotein(a) [Lp(a)] levels are linked to increased risk for both ischemic and hemorrhagic strokes. This association is particularly strong in men and younger individuals within the Chinese Han population.

Area of Science:

  • Cardiovascular Science
  • Neurology
  • Biochemistry

Background:

  • Lipoprotein(a) [Lp(a)] is a known risk factor for coronary heart disease.
  • The association between Lp(a) levels and stroke risk, particularly different stroke subtypes, remains less defined.
  • Understanding Lp(a)'s role in stroke is crucial for risk stratification and prevention strategies.

Purpose of the Study:

  • To investigate the association between serum Lipoprotein(a) [Lp(a)] concentrations and the risk of ischemic and hemorrhagic stroke.
  • To evaluate potential differences in this association based on stroke type, sex, and age.

Main Methods:

  • A single-center, retrospective case-control study involving 1,953 ischemic stroke patients, 196 hemorrhagic stroke patients, and matched healthy controls.
  • Lipoprotein(a) [Lp(a)] levels were measured using the latex agglutination turbidimetric method.
  • Conditional logistic regression models were employed to assess the association between Lp(a) quartiles and stroke risk, adjusting for relevant covariates.

Main Results:

  • Median Lp(a) levels were significantly higher in both ischemic and hemorrhagic stroke patients compared to controls.
  • Elevated Lp(a) showed a significant positive association with increased risk for both ischemic stroke (ORs ranging from 2.03 to 2.36) and hemorrhagic stroke (ORs ranging from 1.93 to 3.24) across higher quartiles.
  • Stratified analyses indicated a significant association between elevated Lp(a) and ischemic stroke risk in men, with a trend towards higher risk in younger patients.

Conclusions:

  • Elevated serum Lipoprotein(a) [Lp(a)] is a significant independent risk factor for both ischemic and hemorrhagic stroke in the Chinese Han population.
  • The risk associated with elevated Lp(a) is more pronounced in men and younger individuals.
  • These findings highlight Lp(a) as a potential biomarker for stroke risk assessment.
Abstract

Related Concept Videos

Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
263
Atherosclerosis I: Introduction01:30

Atherosclerosis I: Introduction

Atherosclerosis is a progressive disorder characterized by the buildup of plaques on the arterial inner wall, causing them to narrow and harden over time. These plaques comprise lipids, calcium, blood components, carbohydrates, and fibrous tissue. The process primarily affects the intima of large and medium-sized arteries, reducing blood flow in any artery.Etiology and risk factorsThe cause of atherosclerosis is multifactorial, involving a complex interplay among endothelial injury, lipid...
662
Blood Studies for Cardiovascular System III: Serum Lipid Profile01:25

Blood Studies for Cardiovascular System III: Serum Lipid Profile

Understanding serum lipids is crucial for maintaining cardiovascular health and preventing heart disease and stroke.
Serum lipids are fats and fatty substances in the blood and are crucial for various bodily functions, including energy storage, cellular structure, and hormone production. Serum lipids consist of cholesterol, triglycerides, and phospholipids.
Cholesterol is a soft, fat-like substance found in all body cells. It is crucial for producing hormones, vitamin D, and substances that aid...
504
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
530
Genome-wide Association Studies-GWAS01:11

Genome-wide Association Studies-GWAS

Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...
15.2K
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
781